🎯 check PF-06821497 product page
PF-06821497 is a highly selective EZH2 inhibitor. It blocks PRC2 signaling by reducing H3K27me3, inhibiting cancer cell growth.
PF-06821497 MOA:Targeting EZH2/Epigenetic Regulation for Prostate Cancer
🎯 check PF-06821497 product page
PF-06821497 is a highly selective EZH2 inhibitor. It blocks PRC2 signaling by reducing H3K27me3, inhibiting cancer cell growth.